Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.

CNAT

Conatus Pharmaceuticals (CNAT)

Conatus Pharmaceuticals Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:CNAT
FechaHoraFuenteTítuloSímboloCompañía
05/06/202015:03Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CNATConatus Pharmaceuticals Inc
29/05/202015:11Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CNATConatus Pharmaceuticals Inc
29/05/202015:10Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:CNATConatus Pharmaceuticals Inc
18/05/202015:11Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:CNATConatus Pharmaceuticals Inc
18/05/202007:00GlobeNewswire Inc.Leading Independent Proxy Advisory Firms Recommend Conatus Pharmaceuticals Shareholders Vote in Favor of its Merger with Hist...NASDAQ:CNATConatus Pharmaceuticals Inc
14/05/202007:00GlobeNewswire Inc.Histogen Publishes Preclinical Data on its HST 004 Spinal Disc ProgramNASDAQ:CNATConatus Pharmaceuticals Inc
11/05/202007:00GlobeNewswire Inc.Histogen Receives US FDA IND Approval to Initiate Phase 1b/2a Trial of HST 001 in Androgenic AlopeciaNASDAQ:CNATConatus Pharmaceuticals Inc
07/05/202015:05GlobeNewswire Inc.The Conatus Pharmaceuticals Special Meeting of Stockholders Seeking Approval for Proposed Merger with Histogen Inc. will Reco...NASDAQ:CNATConatus Pharmaceuticals Inc
01/05/202015:32Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CNATConatus Pharmaceuticals Inc
01/05/202015:05GlobeNewswire Inc.Conatus Pharmaceuticals Reports First Quarter 2020 Financial Results and Strategic Process UpdateNASDAQ:CNATConatus Pharmaceuticals Inc
20/04/202007:00GlobeNewswire Inc.Histogen Announces Investigational Device Exemption Application for HST 002NASDAQ:CNATConatus Pharmaceuticals Inc
15/04/202007:00GlobeNewswire Inc.Histogen Publishes New Preclinical Data on its HST 003 Orthopedic ProgramNASDAQ:CNATConatus Pharmaceuticals Inc
06/04/202007:00GlobeNewswire Inc.Histogen Announces Investigational New Drug Application Amendment for HST 001NASDAQ:CNATConatus Pharmaceuticals Inc
02/04/202005:01Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:CNATConatus Pharmaceuticals Inc
01/04/202015:48Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:CNATConatus Pharmaceuticals Inc
30/03/202016:03Edgar (US Regulatory)Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)NASDAQ:CNATConatus Pharmaceuticals Inc
11/03/202016:02Edgar (US Regulatory)Annual Report (10-k)NASDAQ:CNATConatus Pharmaceuticals Inc
11/03/202015:45GlobeNewswire Inc.Conatus Pharmaceuticals Reports 2019 Financial Results and Strategic Process UpdateNASDAQ:CNATConatus Pharmaceuticals Inc
07/02/202016:09Edgar (US Regulatory)Securities Registration: Business Combination (s-4)NASDAQ:CNATConatus Pharmaceuticals Inc
06/02/202007:00PR Newswire (US)Histogen to Present at BIO CEO & Investor ConferenceNASDAQ:CNATConatus Pharmaceuticals Inc
05/02/202013:11Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CNATConatus Pharmaceuticals Inc
30/01/202007:00PR Newswire (US)Histogen and Allergan Expand Cell Conditioned Media (CCM) Skin Care PartnershipNASDAQ:CNATConatus Pharmaceuticals Inc
28/01/202015:05GlobeNewswire Inc.Conatus Pharmaceuticals and Histogen Enter into Definitive Merger AgreementNASDAQ:CNATConatus Pharmaceuticals Inc
18/11/201915:05GlobeNewswire Inc.Conatus Pharmaceuticals Appoints Kathy Scott as Independent Board MemberNASDAQ:CNATConatus Pharmaceuticals Inc
05/11/201915:05GlobeNewswire Inc.Conatus Pharmaceuticals Reports Third Quarter 2019 Financial ResultsNASDAQ:CNATConatus Pharmaceuticals Inc
06/08/201915:05GlobeNewswire Inc.Conatus Pharmaceuticals Reports Second Quarter 2019 Financial Results and Program UpdatesNASDAQ:CNATConatus Pharmaceuticals Inc
24/06/201915:06GlobeNewswire Inc.Conatus to Explore Strategic Alternatives and Implement Restructuring PlanNASDAQ:CNATConatus Pharmaceuticals Inc
24/06/201915:05GlobeNewswire Inc.Conatus Announces Results from ENCORE-LF and ENCORE-PH Phase 2b Clinical Trials in NASH CirrhosisNASDAQ:CNATConatus Pharmaceuticals Inc
02/05/201915:05GlobeNewswire Inc.Conatus Pharmaceuticals Reports First Quarter 2019 Financial Results and Program UpdatesNASDAQ:CNATConatus Pharmaceuticals Inc
30/04/201906:30GlobeNewswire Inc.Conatus Pharmaceuticals Announces Publication Demonstrating that Emricasan Ameliorates Portal Hypertension, Improves Liver St...NASDAQ:CNATConatus Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:CNAT

Su Consulta Reciente